Celentyx Ltd | Immunology CRO
  • Home
  • Immunology Assays
    • B Cells
    • Haemolysis Testing
    • Human microglia
    • Macrophages/Monocytes
    • Neutrophils/Granulocytes
    • Phagocytosis Assays
    • Regulatory T cells
    • Spheroid Killing Assays
    • Suppression Assays
    • T Cells Activation Assays
    • T Cell Exhaustion Assays
    • Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays
    • Tumour Cell Killing
  • Therapeutic Area
    • Autoimmunity & Inflammation
    • COVID-19
    • Fibrosis
    • Immuno-oncology
    • Neuroinflammation
  • Services
    • Assays on Patient Cells
    • Bespoke Services & Assay Development
    • CyTOF
    • ELISA
    • ELISpot
    • ELLA
    • Flow Cytometry
    • Imaging: High-content
    • Luminex
    • Phosphoflow
    • Seahorse Metabolic Assays
  • About
    • People
    • Publications
    • News
    • Careers
  • Contact

Suppression Assays

Home > Immunology Assays > Suppression Assays

Assays for measuring suppression of T cell proliferation by regulatory T cells, tumour cells and myeloid-derived suppressor cells (MDSCs)

The tumour microenvironment contains multiple suppressive cell types (including regulatory T cells and myeloid-derived suppressor cells) that can prevent an immune response. Conversely in autoimmune and inflammatory diseases, these cells may be defective, or, it may be beneficial to boost their function or numbers. 

Celentyx offers a range of assays for studying the function of regulatory T cells or suppressive myeloid cells, both in terms of phenotypic induction by measuring by FOXP3 expression (A, regulatory T cells) or surface marker expression (B, myeloid-derived suppressor cells), or by functional assays (C, regulatory T cells;  D, myeloid-derived suppressor cells). These flow-cytometric assays can be performed in plate-based formats for screening with human primary cells from healthy donors or from patients. Finally tumour cells themselves can be highly suppressive through a variety of mechanisms (E)
​Assays may be suitable for evaluating modulators of Arginase, CD28, CD39, CD73, CD80, CD86, CTLA-4, Fas, FasL, GITR, IDO, LAG-3, PD-1, PDL-1, PDL-2, TGFb, TIGIT, TIM-3, and others.
Further Immunology Assays
B Cells
Haemolysis Testing
​
Human Microglia
​Macrophages/Monocytes
​Neutrophils/Granulocytes
​Phagocytosis Assays
Regulatory T cells​
Spheroid Killing Assay​s
​T Cell Activation Assays
​
T Cell Exhaustion Assays

Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays​
Tumour Cell Killing Assays​

Picture
Picture
Picture
Picture
Picture
Picture

FIND US

Celentyx Ltd
Birmingham Research Park
97 Vincent Drive
Birmingham
B15 2SQ
United Kingdom
Celentyx Innovation Lab
BioEscalator Innovation Building
Roosevelt Drive
Oxford
​OX3 7FZ
United Kingdom

    CONTACT US

Submit
Web Hosting by Bluehost
  • Home
  • Immunology Assays
    • B Cells
    • Haemolysis Testing
    • Human microglia
    • Macrophages/Monocytes
    • Neutrophils/Granulocytes
    • Phagocytosis Assays
    • Regulatory T cells
    • Spheroid Killing Assays
    • Suppression Assays
    • T Cells Activation Assays
    • T Cell Exhaustion Assays
    • Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays
    • Tumour Cell Killing
  • Therapeutic Area
    • Autoimmunity & Inflammation
    • COVID-19
    • Fibrosis
    • Immuno-oncology
    • Neuroinflammation
  • Services
    • Assays on Patient Cells
    • Bespoke Services & Assay Development
    • CyTOF
    • ELISA
    • ELISpot
    • ELLA
    • Flow Cytometry
    • Imaging: High-content
    • Luminex
    • Phosphoflow
    • Seahorse Metabolic Assays
  • About
    • People
    • Publications
    • News
    • Careers
  • Contact